A detailed history of True Wealth Design, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, True Wealth Design, LLC holds 3,443 shares of UTHR stock, worth $1.38 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
3,443
Previous 3,506 1.8%
Holding current value
$1.38 Million
Previous $805 Million 36.18%
% of portfolio
0.27%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$228.26 - $319.04 $14,380 - $20,099
-63 Reduced 1.8%
3,443 $1.1 Billion
Q1 2024

May 14, 2024

BUY
$210.76 - $249.51 $40,044 - $47,406
190 Added 5.73%
3,506 $805 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $9,239 - $11,048
-43 Reduced 1.28%
3,316 $729 Million
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $711,291 - $833,589
3,358 Added 335800.0%
3,359 $759 Million
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $205 - $232
1 New
1 $221,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $18.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.